1 |
Cha, H. J., Jeong, M. J. and Kleinman, H. K. 2003. Role of thymosin beta4 in tumor metastasis and angiogenesis. J. Natl. Cancer Inst. 95, 1674-1680.
DOI
ScienceOn
|
2 |
Collins, A. T., Berry, P. A., Hyde, C., Stower, M. J. and Maitland, N. J. 2005. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65, 10946-10951.
DOI
ScienceOn
|
3 |
Corbeil, D., Roper, K., Hellwig, A., Tavian, M., Miraglia, S., Watt, S. M., Simmons, P. J., Peault, B., Buck, D. W. and Huttner, W. B. 2000. The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J. Biol. Chem. 275, 5512-5520.
DOI
|
4 |
Eramo, A., Lotti, F., Sette, G., Pilozzi, E., Biffoni, M., Di Virgilio, A., Conticello, C., Ruco, L., Peschle, C. and De Maria, R. 2008. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 15, 504-514.
DOI
|
5 |
Grant, D. S., Rose, W., Yaen, C., Goldstein, A., Martinez, J. and Kleinman, H. 1999. Thymosin beta4 enhances endothelial cell differentiation and angiogenesis. Angiogenesis 3, 125-135.
DOI
ScienceOn
|
6 |
Hermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M., Bruns, C. J. and Heeschen, C. 2007. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Stem Cell 1, 313-323.
|
7 |
Iguchi, K., Usami, Y., Hirano, K., Hamatake, M., Shibata, M. and Ishida, R. 1999. Decreased thymosin beta4 in apoptosis induced by a variety of antitumor drugs. Biochem. Pharmacol. 57, 1105-1111.
DOI
ScienceOn
|
8 |
Ji, P., Diederichs, S., Wang, W., Boing, S., Metzger, R., Schneider, P. M., Tidow, N., Brandt, B., Buerger, H., Bulk, E., Thomas, M., Berdel, W. E., Serve, H. and Muller-Tidow, C. 2003. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22, 8031-8041.
DOI
|
9 |
Jo, J. O., Kang, Y. J., Ock, M. S., Kleinman, H. K., Chang, H. K. and Cha, H. J. 2011. Thymosin beta4 expression in human tissues and in tumors using tissue microarrays. Appl. Immunohistochem. Mol. Morphol. 19, 160-167.
DOI
|
10 |
Kobayashi, T., Okada, F., Fujii, N., Tomita, N., Ito, S., Tazawa, H., Aoyama, T., Choi, S. K., Shibata, T., Fujita, H. and Hosokawa, M. 2002. Thymosin-beta4 regulates motility and metastasis of malignant mouse fibrosarcoma cells. Am. J. Pathol. 160, 869-882.
DOI
|
11 |
Larsson, L. I. and Holck, S. 2007. Occurrence of thymosin beta4 in human breast cancer cells and in other cell types of the tumor microenvironment. Hum. Pathol. 38, 114-119.
DOI
ScienceOn
|
12 |
Low, T. L. and Goldstein, A. L. 1982. Chemical characterization of thymosin beta 4. J. Biol. Chem. 257, 1000-1006.
|
13 |
Malinda, K. M., Sidhu, G. S., Mani, H., Banaudha, K., Maheshwari, R. K., Goldstein, A. L. and Kleinman, H. K. 1999. Thymosin beta4 accelerates wound healing. J. Invest. Dermatol. 113, 364-368.
DOI
ScienceOn
|
14 |
Miraglia, S., Godfrey, W., Yin, A. H., Atkins, K., Warnke, R., Holden, J. T., Bray, R. A., Waller, E. K. and Buck, D. W. 1997. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 90, 5013-5021.
|
15 |
Philp, D., Nguyen, M., Scheremeta, B., St-Surin, S., Villa, A. M., Orgel, A., Kleinman, H. K. and Elkin, M. 2004. Thymosin beta4 increases hair growth by activation of hair follicle stem cells. FASEB J. 18, 385-387.
|
16 |
Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C. and De Maria, R. 2007. Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111-115.
DOI
|
17 |
Ricci-Vitiani, L., Mollinari, C., di Martino, S., Biffoni, M., Pilozzi, E., Pagliuca, A., de Stefano, M. C., Circo, R., Merlo, D., De Maria, R. and Garaci, E. 2010. Thymosin beta4 targeting impairs tumorigenic activity of colon cancer stem cells. FASEB J. 24, 4291-4301.
DOI
|
18 |
Safer, D., Elzinga, M. and Nachmias, V. T. 1991. Thymosin beta 4 and Fx, an actin-sequestering peptide, are indistinguishable. J. Biol. Chem. 266, 4029-4032.
|
19 |
Sanai, N., Alvarez-Buylla, A. and Berger, M. S. 2005. Neural stem cells and the origin of gliomas. N. Engl. J. Med. 353, 811-822.
DOI
|
20 |
Safer, D., Golla, R. and Nachmias, V. T. 1990. Isolation of a 5-kilodalton actin-sequestering peptide from human blood platelets. Proc. Natl. Acad. Sci. USA 87, 2536-2540.
DOI
ScienceOn
|
21 |
Santelli, G., Califano, D., Chiappetta, G., Vento, M. T., Bartoli, P. C., Zullo, F., Trapasso, F., Viglietto, G. and Fusco, A. 1999. Thymosin beta-10 gene overexpression is a general event in human carcinogenesis. Am. J. Pathol. 155, 799-804.
DOI
|
22 |
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D. and Dirks, P. B. 2004. Identification of human brain tumour initiating cells. Nature 432, 396-401.
DOI
ScienceOn
|
23 |
Steiniger, S. C., Coppinger, J. A., Kruger, J. A., Yates, J., 3rd and Janda, K. D. 2008. Quantitative mass spectrometry identifies drug targets in cancer stem cell-containing side population. Stem Cells 26, 3037-3046.
DOI
|
24 |
Van Troys, M., Dewitte, D., Goethals, M., Carlier, M. F., Vandekerckhove, J. and Ampe, C. 1996. The actin binding site of thymosin beta 4 mapped by mutational analysis. EMBO J. 15, 201-210.
|
25 |
Vermeulen, L., Sprick, M. R., Kemper, K., Stassi, G. and Medema, J. P. 2008. Cancer stem cells--old concepts, new insights. Cell Death Differ. 15, 947-958.
DOI
|
26 |
Wang, W. S., Chen, P. M., Hsiao, H. L., Wang, H. S., Liang, W. Y. and Su, Y. 2004. Overexpression of the thymosin beta-4 gene is associated with increased invasion of SW480 colon carcinoma cells and the distant metastasis of human colorectal carcinoma. Oncogene 23, 6666-6671.
DOI
ScienceOn
|
27 |
Yin, A. H., Miraglia, S., Zanjani, E. D., Almeida-Porada, G., Ogawa, M., Leary, A. G., Olweus, J., Kearney, J. and Buck, D. W. 1997. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90, 5002-5012.
|
28 |
Young, J. D., Lawrence, A. J., MacLean, A. G., Leung, B. P., McInnes, I. B., Canas, B., Pappin, D. J. and Stevenson, R. D. 1999. Thymosin beta 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoids. Nat. Med. 5, 1424-1427.
DOI
ScienceOn
|
29 |
Yin, S., Li, J., Hu, C., Chen, X., Yao, M., Yan, M., Jiang, G., Ge, C., Xie, H., Wan, D., Yang, S., Zheng, S. and Gu, J. 2007. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int. J. Cancer 120, 1444-1450.
DOI
|